2msh: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
 
(9 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Theoretical Model'''
{{Theoretical_model}}


The entry 2MSH is a Theoretical Model titled 'TRITHIOL ALPHA MELANOCYTE STIMULATING HORMONE CYCLIZED THROUGH RHENIUM COORDINATION'.
==TRITHIOL ALPHA MELANOCYTE STIMULATING HORMONE CYCLIZED THROUGH RHENIUM COORDINATION==
<StructureSection load='2msh' size='340' side='right'caption='[[2msh]]' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2MSH FirstGlance]. <br>
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2msh FirstGlance], [https://www.ebi.ac.uk/pdbsum/2msh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2msh ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
alpha-Melanocyte stimulating hormone (alpha-MSH) analogs, cyclized through site-specific rhenium (Re) and technetium (Tc) metal coordination, were structurally characterized and analyzed for their abilities to bind alpha-MSH receptors present on melanoma cells and in tumor-bearing mice. Results from receptor-binding assays conducted with B16 F1 murine melanoma cells indicated that receptor-binding affinity was reduced to approximately 1% of its original levels after Re incorporation into the cyclic Cys4,10, D-Phe7-alpha-MSH4-13 analog. Structural analysis of the Re-peptide complex showed that the disulfide bond of the original peptide was replaced by thiolate-metal-thiolate cyclization. A comparison of the metal-bound and metal-free structures indicated that metal complexation dramatically altered the structure of the receptor-binding core sequence. Redesign of the metal binding site resulted in a second-generation Re-peptide complex (ReCCMSH) that displayed a receptor-binding affinity of 2.9 nM, 25-fold higher than the initial Re-alpha-MSH analog. Characterization of the second-generation Re-peptide complex indicated that the peptide was still cyclized through Re coordination, but the structure of the receptor-binding sequence was no longer constrained. The corresponding 99mTc- and 188ReCCMSH complexes were synthesized and shown to be stable in phosphate-buffered saline and to challenges from diethylenetriaminepentaacetic acid (DTPA) and free cysteine. In vivo, the 99mTcCCMSH complex exhibited significant tumor uptake and retention and was effective in imaging melanoma in a murine-tumor model system. Cyclization of alpha-MSH analogs via 99mTc and 188Re yields chemically stable and biologically active molecules with potential melanoma-imaging and therapeutic properties.


[[Category:Theoretical Model]]
Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.,Giblin MF, Wang N, Hoffman TJ, Jurisson SS, Quinn TP Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12814-8. PMID:9788997<ref>PMID:9788997</ref>


 
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 30 09:58:45 2008''
</div>
<div class="pdbe-citations 2msh" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Theoretical Model]]
[[Category: Large Structures]]
[[Category: Giblin, M F]]
[[Category: Hoffman, T J]]
[[Category: Jurisson, S S]]
[[Category: Quinn, T P]]
[[Category: Wang, N]]